Medpace Holdings Inc buy UBS Group AG
Start price
15.02.24
/
50%
€369.50
Target price
15.02.25
€419.64
Performance (%)
-4.11%
Price
09.08.24
€354.30
Summary
This prediction is currently active. With a performance of -4.11%, the BUY prediction for Medpace Holdings Inc by UBS_Group_AG is down slightly. This prediction currently runs until 15.02.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Medpace Holdings Inc | 2.547% | 2.547% |
iShares Core DAX® | 0.393% | -2.618% |
iShares Nasdaq 100 | 0.394% | -10.309% |
iShares Nikkei 225® | 1.038% | -8.365% |
iShares S&P 500 | -0.046% | -4.991% |
Comments by UBS_Group_AG for this prediction
In the thread Medpace Holdings Inc diskutieren
Medpace Holdings, Inc. (NASDAQ: MEDP) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $452.00 price target on the stock, up previously from $282.00.
Ratings data for MEDP provided by MarketBeat